Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Stroncek

Showing results (181-190 of 213) with videos related to

Pageof 22
Sort By:
Nature|March 3, 2016
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesisChi Ma, Aparna H Kesarwala, Tobias Eggert, et al.
Journal of Translational Medicine|March 17, 2012
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancerDavid F Stroncek, Carolina Berger, Martin A Cheever, et al.
Blood Advances|December 18, 2025
10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemiaAlexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, et al.
Molecular Cancer Therapeutics|February 26, 2021
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T CellsAlka Dwivedi, Atharva Karulkar, Sarbari Ghosh, et al.
Oncoimmunology|September 14, 2016
TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancerLauren V Wood, Antonio Fojo, Brenda D Roberson, et al.
JCI Insight|December 8, 2017
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapyChristopher A Klebanoff, Joseph G Crompton, Anthony J Leonardi, et al.
Journal for Immunotherapy of Cancer|June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriersJames L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple MyelomaJennifer N Brudno, Irina Maric, Steven D Hartman, et al.
Frontiers in Oncology|January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Blood|October 31, 2012
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor ProgramMichael A Pulsipher, Pintip Chitphakdithai, Brent R Logan, et al.
Pageof 22

Showing results (181-190 of 213) with videos related to

Sort By:
Pageof 22
Nature|March 3, 2016
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesisChi Ma, Aparna H Kesarwala, Tobias Eggert, et al.
Journal of Translational Medicine|March 17, 2012
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancerDavid F Stroncek, Carolina Berger, Martin A Cheever, et al.
Blood Advances|December 18, 2025
10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemiaAlexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, et al.
Molecular Cancer Therapeutics|February 26, 2021
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T CellsAlka Dwivedi, Atharva Karulkar, Sarbari Ghosh, et al.
Oncoimmunology|September 14, 2016
TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancerLauren V Wood, Antonio Fojo, Brenda D Roberson, et al.
JCI Insight|December 8, 2017
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapyChristopher A Klebanoff, Joseph G Crompton, Anthony J Leonardi, et al.
Journal for Immunotherapy of Cancer|June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriersJames L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple MyelomaJennifer N Brudno, Irina Maric, Steven D Hartman, et al.
Frontiers in Oncology|January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Blood|October 31, 2012
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor ProgramMichael A Pulsipher, Pintip Chitphakdithai, Brent R Logan, et al.
Pageof 22